Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers

Journal of Alternative and Complementary Medicine

Volumn 17, Issue 9, 2011, Pages 827-833

  Allen, Jason ^a,b   Bradley, Ryan D ^a,b  

^a BASTYR UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CALCIUM PHOSPHATE DIBASIC; CREATININE; GLUTATHIONE; ISOPROSTANE; PLACEBO;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE LEVEL; FEMALE; FLATULENCE; FLUSHING; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; LOOSE FECES; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TANDEM LIQUID CHROMATOGRAPHY; URINARY EXCRETION; WEIGHT GAIN;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BIOLOGICAL MARKERS; DEOXYGUANOSINE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ERYTHROCYTES; F2-ISOPROSTANES; FEMALE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES; YOUNG ADULT;

EID: 80052236410     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2010.0716     Document Type: Article

References (35)

1. Dickinson DA, Forman HJ. Glutathione in defense and signaling: Lessons from a small thiol. Ann N Y Acad Sci 2002;973:488-504. (Pubitemid 36131049)
2. Exner R, Wessner B, Manhart N, Roth E. Therapeutic potential of glutathione. Wien Klin Wochenschr 2000;112:610-616. (Pubitemid 30621366)
3. Lee DH, Steffes MW, Jacobs DR Jr. Can persistent organic pollutants explain the association between serum gammaglutamyltransferase and type 2 diabetes? Diabetologia 2008;51:402-407.
4. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23: 599-622. (Pubitemid 35191625)
5. Liu RM, Dickinson DA. Decreased synthetic capacity underlies the age-associated decline in glutathione content in Fisher 344 rats. Antioxid Redox Signal 2003;5:529-536. (Pubitemid 37315139)
6. Favilli F, Marraccini P, Iantomasi T, Vincenzini MT. Effect of orally administered glutathione on glutathione levels in some organs of rats: Role of specific transporters. Br J Nutr 1997;78:293-300. (Pubitemid 27367920)
7. Hagen TM, Wierzbicka GT, Bowman BB, et al. Fate of dietary glutathione: Disposition in the gastrointestinal tract. Am J Physiol 1990;259:G530-G535. (Pubitemid 20340459)
8. Bhatia S, Shukla R, Venkata Madhu S, et al. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003;36:557-562. (Pubitemid 37244019)
9. Jariwalla RJ, Lalezari J, Cenko D, et al. Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infection. J Altern Complement Med 2008;14:139-146. (Pubitemid 351364398)
10. Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr 2004;134:489-492. (Pubitemid 38298485)
11. Klimberg VS, McClellan JL, Organ CH Jr. Honorary lectureship: Glutamine, cancer, and its therapy. Am J Surg 1996;172:418-424.
12. Prousky J. The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione. Evid Based Complement Altern Med 2008;5:27-35. (Pubitemid 351301961)
13. Hauser RA, Lyons KE, McClain T, et al. Randomized, double- blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Mov Disord 2009;24:979-983.
14. Franco RSO, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human disease. Arch Physiol Biochem 2007;113:234-258.
15. Araujo AR, Saraiva ML, Lima JL. Determination of total and oxidized glutathione in human whole blood with a sequential injection analysis system. Talanta 2008;74:1511-1519.
16. Redegeld FA, van Opstal MA, Houdkamp E, van Bennekom WP. Determination of glutathione in biological material by flow-injection analysis using an enzymatic recycling reaction. Anal Biochem 1988;174:489-495.
17. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-522.
18. Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 2006;1:3159-3165.
19. Roberts JC, Francetic DJ. The importance of sample preparation and storage in glutathione analysis. Anal Biochem 1993;211:183-187. (Pubitemid 23207714)
20. Amores-Sanchez MI, Medina MA. Glutamine, as a precursor of glutathione, and oxidative stress. Mol Genet Metab 1999;67:100-105. (Pubitemid 29393236)
21. Allen J. Inhaled glutathione for the prevention of air pollution-related health effects: A brief review. Altern Ther Health Med 2008;14:42-44.
22. Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992; 43:667-669.
23. Milla P, Airoldi M, Weber G, et al. Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: Effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity. Anticancer Drugs 2009;20:396-402.
24. Smyth JF, Bowman A, Perren T, et al. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trial. Ann Oncol 1997;8:569-673.
25. Cascinu S, Cordella L, Del Ferro E, et al. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: A randomized double-blind placebo-controlled trial. J Clin Oncol 1995;13:26-32.
26. Gmitterova K, Heinemann U, Gawinecka J, et al. 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases. Neurodegener Dis 2009;6:263-269.
27. Himmetoglu S, Dincer Y, Bozcali E, et al. Oxidative DNA damage and antioxidant defense after reperfusion in acute myocardial infarction. J Investig Med 2009;57:595-599.
28. Yano T, Shoji F, Baba H, et al. Significance of the urinary 8- OHdG level as an oxidative stress marker in lung cancer patients. Lung Cancer 2009;63:111-114.
29. Garratt LW, Mistry V, Singh R, et al. Interpretation of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine is adversely affected by methodological inaccuracies when using a commercial ELISA. Free Radic Biol Med 2010;48:1460-1464.
30. Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment. Circulation 2002;106:1211-1218. (Pubitemid 34988638)
31. Bradley R, Oberg EB, Calabrese C, Standish LJ. Algorithm for complementary and alternative medicine practice and research in type 2 diabetes. J Altern Complement Med 2007; 13:159-175.
32. Bradley R, Kozura E, Buckle H, et al. Description of clinical risk factor changes during naturopathic care for type 2 diabetes. J Altern Complement Med 2009;15:633-638.
33. Bradley R, Kozura E, Kaltunas J, et al. Observed changes in risk during naturopathic treatment of hypertension. Evid Based Complement Alternat Med 2011;2011:826751.
34. Shavit L, Korenfeld R, Lifschitz M, et al. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease. J Interv Cardiol 2009;22:556-563.
35. Sadowska AM, Verbraecken J, Darquennes K, De Backer WA. Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis 2006;1:425-434.